Gastrointestinal pH, motility/transit and permeability in cystic fibrosis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 23, Issue 5, 1996, Pages 513-523

  Gregory, P C ^a  

^a Solvay Pharma Deutschland ^*  (Germany)

Author keywords

Cystic fibrosis; Gastrointestinal motility; Gastrointestinal pH; Intestinal permeability; Intestinal transit

Indexed keywords

BICARBONATE; CELLOBIOSE; DEXTRAN; LACTULOSE; MANNITOL; MICROSPHERE; NEUROTENSIN; OXYNTOMODULIN; PANCREAS ENZYME; PEPTIDE YY; RAFFINOSE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

COLON DISEASE; CYSTIC FIBROSIS; DUODENUM PH; ENTERIC COATED TABLET; ENZYME REPLACEMENT; ESOPHAGUS MOTILITY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; HUMAN; HYDROGEN BREATH TEST; INTESTINE MUCOSA PERMEABILITY; LOWER ESOPHAGUS SPHINCTER PRESSURE; PRIORITY JOURNAL; REVIEW; STOMACH EMPTYING;

CYSTIC FIBROSIS; DIGESTIVE SYSTEM; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; HUMANS; HYDROGEN-ION CONCENTRATION; INTESTINAL ABSORPTION; PERMEABILITY;

EID: 0030447497     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199612000-00001     Document Type: Review

References (112)

1. Riordan JR, Rommens JM, Kerem BS, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-73.
2. Kerem BS, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245:1073-80.
3. Knowles MR, Stutts MJ, Spock A, Fischer N, Gatzy JT, Boucher RC. Abnormal ion permeation through cystic fibrosis respiratory epithelium. Science 1983;221:1067-70.
4. Welsh MJ, Fick RB. Cystic fibrosis. J Clin Invest 1987;80: 1523-6.
5. Berschneider HM, Knowles MR, Azizkham RG, et al. Altered intestinal chloride transport in cystic fibrosis. FASEB J 1988;2:2625-9.
6. Cheng SH, Gregory RJ, Marshall J, et al. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 1990;63:827-34.
7. Lebenthal E, Rolston DDK, Holsclaw DS Jr. Enzyme therapy for pancreatic insufficiency: present status and future needs. Pancreas 1994;9:1-12.
8. Thomson M, Clague A, Cleghorn GJ, Shepherd RW. Comparative in vitro and in vivo studies of enteric-coated pancrelipase preparations for pancreatic insufficiency. J Pediatr Gastroenterol Nutr 1993;17:407-13.
9. Kraisinger M, Hochhaus G, Stecebko A, Bowser E, Hendeles L. Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in vitro performance of microencapsulated formulations. J Clin Pharmacol 1994; 34:158-66.
10. Bruno MJ, Rauws EAJ, Hoek FJ, Tytgat GNJ. Comparative effects of adjuvant cimetidine and omeprazole during pancreatic enzyme replacement therapy. Dig Dis Sci 1994; 39:988-92.
11. Smyth RL, van Velzen R, Smyth AR, Lloyd DA, Heaf DP. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet 1994;343:85-6.
12. Oades PJ, Bush A, Ong PS, Brereton RJ. High strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis. Lancet 1994;343:109.
13. Campbell CA, Forrest J, Musgrove C. High strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis. Lancet 1994;343:109-10.
14. Zerin JM, Kuhn-Fulton J, White SJ, et al. Colonic strictures in children with cystic fibrosis. Pediatr Radiol 1995; 194:223-6.
15. Graham DY. Enzyme replacement therapy of exocrine pancreatic insufficiency in man. Relation between in vitro enzyme activities and in vivo potency in commercial pancreatic extracts. N Engl J Med 1977;296:1314-7.
16. Peschke GJ. Active components and galenic aspects of enzyme preparations. In: Lankisch PG, ed. Pancreatic enzymes in health and disease. Berlin: Springer-Verlag, 1991: 55-64.
17. Meyer JH, Porter-Fink V, Elashoff J, Dressman J, Amidon GL. Human post-cibal gastric emptying of 1-3 mm spheres. Gastroenterology 1988;94:1315-25.
18. Weiner K, Grahn LS, Reedy T, Elashoff J, Meyer JH. Simultaneous gastric emptying of two solid foods. Gastroenterology 1981;81:257-66.
19. Meyer JH. Delivery of pancreatin in microsphere preparations transit, timing, physiological needs. In: Lankisch PG, ed. Pancreatic enzymes in health and disease. Berlin: Springer-Verlag, 1991:71-88.
20. Gan KH, Geus WP, Heijerman HGM, Bakker W, Lamers CBHW. In vitro dissolution profiles of enteric coated microsphere pancreatin preparations at different pH values. Gastroenterology 1995;108(suppl):A554.
21. Cameron DJS, Pitcher-Wilmott R, Milla PJ, et al. The effect of cimetidine on meal-stimulated gastric function and exogenous pancreatic enzymes in cystic fibrosis. Hum Clin Nutr 1982;36C:475-81.
22. Cox KL, Isenberg JN, Ament MEI. Gastric acid hypersecretion in cystic fibrosis. J Pediatr Gastroenterol Nutr 1981;1:559-65.
23. Cox KL, Isenberg JN. Hypersecretion of gastric acid in patients with pancreatic insufficiency due to cystic fibrosis. Gastroenterology 1978;74:1022.
24. Naimi D, Guéant JL, Hambaba L, Vidailhet M, Monin B, Nicolas JP. Gastric intrinsic factor hypersecretion stimulated by pentagastrin in cystic fibrosis. J Pediatr Gastroenterol Nutr 1987;6:899-90.
25. Kopel FB, Barbero GJ. Gastric acid secretion in cystic fibrosis. Gastroenterology 1967;52:1101.
26. Fieber M, Meschede R, Tolckmitt W. Acidität und peptische Aktivität des Magensaftes bei gesunden und Mucoviscidosiskranken Kindern. Z Kinderheilkd 1975;120:199-209.
27. Dutta SK, Hubbard VS, Appler M. Critical examination of therapeutic efficacy of pH-sensitive enteric-coated pancreatic enzyme preparations in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis. Dig Dis Sci 1988;33:1237-44.
28. Murphy MS, Brunetto AL, Pearson ADJ, et al. Gut hormones and gastrointestinal motility in children with cystic fibrosis. Dig Dis Sci 1992;37:187-92.
29. Adrian TE, McKiernan J, Johnstone DI, et al. Hormonal abnormalities of the pancreas and gut in cystic fibrosis. Gastroenterology 1980;79:460-5.
30. Allen JM, Penketh ARL, Adrian TE, et al. Adult cystic fibrosis: postprandial response of gut regulatory peptides. Gastroenterology 1983;85:1379-83.
31. Walsh JH. Gastrointestinal hormones. In: Johnson LR, ed. Physiology of the gastrointestinal tract, 2nd ed., vol. 1. New York: Raven Press, 1987:181-253.
32. Ellison LT, Ellison RG, Carter CH, et al. The role of hypercapnia and hypoxia in the etiology of peptic ulcerations in patients with chronic obstructive pulmonary emphysema. Am Rev Resp Dis 1964;89:909-16.
33. Youngberg CA, Berardi RR, Howatt WF, et al. Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects. Dig Dis Sci 1987;32:472-80.
34. Abrams CF, Hamosh M, Hubbard VS, Dutta SK, Hamosh P. Lingual lipase in cystic fibrosis. J Clin Invest 1984;73: 374-82.
35. Malagelada JR, Longstreth GF, Summerskill WHJ, Go VLW. Measurement of gastric functions during digestion of ordinary solid meals. Gastroenterology 1976;7:203-10.
36. Ovesen L, Bendtsen F, Tage-Jensen U, Pedersen NT, Gram BR, Rune SJ. Intraluminal pH in the stomach, duodenum, and proximal jejunum in normal subjects and patients with exocrine pancreatic insufficiency. Gastroenterology 1986;90:958-67.
37. Clark GWB, Jamieson JR, Hinder RA, et al. The relationship between gastric pH and the emptying of solid, semi-solid and liquid meals. J Gastrointestinal Motil 1993;5: 273-9.
38. Balasubramanian K, Zentler-Munro PL, Batten JC, Northfield TC. Increased intragastric acid-resistant lipase activity and lipolysis in pancreatic steatorrhea due to cystic fibrosis. Pancreas 1992;7:305-10.
39. Di Magno EP, Malagelada JR, Go VLW, Moertel CG. Fate of orally ingested enzymes in pancreatic insufficiency. N Engl J Med 1977;296:1318-22.
40. Worning H, Müllertz S, Tayson HE, Bang HO. pH and concentration of pancreatic enzymes in aspirates from the human duodenum during digestion of a standard meal. Scand J Gastroenterol 1967;2:23-38.
41. McCloy RF, Greenberg GR, Baron JH. Duodenal pH in health and duodenal ulcer disease. Effect of a meal, coca-cola, smoking and cimetidine. Gut 1984;25:386-92.
42. Knauff RE, Adams JA. Duodenal fluid pH in cystic fibrosis. Clin Chem 1968;14:477-9.
43. Dutta SK, Russell RM, Iber FL. Influence of exocrine pancreatic insufficiency on the intraluminal pH of the proximal small intestine. Am J Dig Dis 1979;24:529-34.
44. Robinson PI, Smith AL, Sly PD. Duodenal pH in cystic fibrosis and its relationship to fat malabsorption. Dig Dis Sci 1990;35:1299-304.
45. Weber AM, Roy CC. Intraduodenal events in cystic fibrosis. J Pediatr Gastroenterol Nutr 1984;3(suppl 1):S113-9.
46. Hogan DL, Martensson BA, Isenberg JI. Is there a CFTR bicarbonate conductance in mammalian duodenal enterocytes? Gastroenterology 1995;108(suppl):A814.
47. Zentler-Munro PL, Fitzpatrick WJF, Batten JC, Northfield TC. Effect of intrajejunal acidity on aqueous phase bile acid and lipid concentrations in pancreatic steatorrhea due to cystic fibrosis. Gut 1984;25:500-7.
48. Zentler-Munro PL, Fine DR, Fitzpatrick WJF, Northfield TC. Effect of intrajejunal acidity on lipid digestion and aqueous solubilisation of bile acids in health, using a new simple method of lipase inactivation. Gut 1984;25:491-9.
49. Dalzell AM, Heaf DP. Oro-caecal transit time and intraluminal pH in cystic fibrosis patients with distal intestinal obstruction syndrome. Acta Univ Carol Med (Praha) 1990; 36:159-60.
50. Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ, Hardcastle JD. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 1988;29:1035-41.
51. Gilbert J, Kelleher J, Littlewood JM, Evans DF, Pye G. Small bowel pH profiles in cystic fibrosis. Pediatric Pulmonology 1990;5(Suppl):270.
52. Gilbert J, Kelleher J, Littlewood JM, Evans DF. Ileal pH in cystic fibrosis. Scand J Gastroenterol 1988;23(suppl 143): 132-4.
53. Robinson CS. The hydrogen ion concentration of human feces. J Biol Chem 1922;52:445-6.
54. Shoshkes M. The hydrogen ion concentration of the feces. Gastroenterology 1947;9:765-72.
55. Agostini L, Down PF, Murison J, Wrong OM. Faecal ammonia and pH during lactulose administration in man; comparison with other cathartics. Gut 1972;13:859-66.
56. Bown RL, Gibson JA, Sladen GE, Hicks B, Dawson AM. Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry device. Gut 1974;15: 999-1004.
57. Jonas A, Diver-Haber A. Bile acid sequestration by the solid phase of stools in cystic fibrosis patients. Dig Dis Sci 1988;33:724-31.
58. Dune PR. Gastrointestinal motility disorders in cystic fibrosis. In: Milla PJ, ed. Disorders of gastrointestinal motility in childhood. New York: J Wiley & Sons, 1988:91-9.
59. Scott RB, O'Loughlin EV, Gall DG. Gastroesophageal reflux in patients with cystic fibrosis. J Pediatr 1985;106: 223-7.
60. Dab I, Malfroot A. Gastroesophageal reflux: a primary defect in cystic fibrosis? Scand J Gastroenterol 1988;143 (suppl):125-31.
61. Malfroot A, Dab I. New insight on gastroesophageal reflux in cystic fibrosis by longitudinal follow-up. Arch Dis Child 1991;66:1339-45.
62. Cucchiara S, Santamaria F, Andreotti MR, et al. Mechanisms of gastrooesophageal reflux in cystic fibrosis. Arch Dis Child 1991;66:617-22.
63. Cavell B. Gastric emptying in infants with cystic fibrosis. Acta Pediatr Scand 1981;70:635-8.
64. Roulet M, Weber AM, Paradis Y, et al. Gastric emptying and lingual lipase activity in cystic fibrosis. Pediatr Res 1980;14:1360-2.
65. Smith HL, Hollins GW, Booth IW, Weller PH. Gastric emptying of liquids in cystic fibrosis. Acta Univ Carol Med (Praha) 1990;36:161-4.
66. Carney BI, Jones KL, Horowitz M, Sun WM, Penagini R, Meyer JH. Gastric emptying of oil and aqueous meal components in pancreatic insufficiency - effects of posture and on appetite. Gastroenterology 1994;106:A473.
67. Long WB, Weiss JB. Rapid gastric emptying of fatty meals in pancreatic insufficiency. Gastroenterology 1974;67: 920-5.
68. Cortot A, Jobin G, Ruskoné A, Bernier JJ. Rapid gastric emptying of lipids in pancreatic insufficiency in man. Gastroenterology 1981;80:1129.
69. Hymen PE. Absent postprandial duodenal motility in a child with cystic fibrosis. Gastroenterology 1986;90: 1274-9.
70. Murphy MS, Nelson R, Eastham EJ. Measurement of small intestinal transit time in children. Acta Paediatr Scand 1988;77:802-6.
71. Vajro P, Silano G, Longo D, Staiano A, Fontanella A. Oro-caecal transit time in healthy and constipated children. Acta Paediatr Scand 1988;77:583-6.
72. Bali A, Stableforth D, Asquith P. Prolonged small-intestinal transit time in cystic fibrosis. Br Med J 1983;287:1011-3.
73. Dalzell AM, Freestone NS, Billington D, Heaf DP. Small intestinal permeability and oro-caecal transit time in cystic fibrosis. Arch Dis Child 1990;65:585-8.
74. Escobar H, Perdomo M, Vasconez F, Camarero C, del Olmo MT, Suárez L. Intestinal permeability to 51-CrEDTA and orocaecal transit time in cystic fibrosis. J Pediatr Gastroenterol Nutr 1992;14:204-7.
75. Perman JA, Rosenstein BJ. Carbohydrate digestion in cystic fibrosis (CF): application of breath H2 measurements. Pediatr Res 1986;20:246A.
76. Read NW, McFarlane A, Kinsman RI, et al. Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucagon. Gastroenterology 1984;86:274-80.
77. Wyman JB, Heaton KW, Manning AP, Wicks CB. Variability of colonic function in healthy subjects. Gut 1978;19: 146-50.
78. Karaus M, Wienbeck M. Colonic motility in humans - a growing understanding. Baillieres Clin Gastroenterol 1991; 5:453-78.
79. Weber AM, Roy CC, Morin CL, Lasalle R. Malabsorption of bile acids in children with cystic fibrosis. N Engl J Med 1973;289:1001-5.
80. Metcalf AM, Phillips SF, Zinsmeister AR, MacCarty RL, Beart RW, Wolff BG. Simplified assessment of segmental colonic transit. Gastroenterology 1987;92:40-7.
81. Casasnovas AB, Cives RV, Jeremias AV, Castro-Gago M, Cadranel S, Sierra RT. Measurement of colonic transit time in children. J Pediatr Gastroenterol Nutr 1991;13:42-5.
82. Proano M, Camilleri M, Phillips SF, Brown ML, Thomforde GM. Transit of solids through the human colon: regional quantification in the unprepared bowel. Am J Physiol 1990;258:G856-62.
83. Rubenstein S, Moss R, Lewiston N. Constipation and meconium ileus equivalent in patients with cystic fibrosis. Pediatrics 1986;78:473-9.
84. Littlewood JM. Cystic fibrosis: gastrointestinal complications. Br Med Bull 1992;48:847-59.
85. Khoshoo V, Udall JN Jr. Meconium ileus equivalent in children and adults. Am J Gastroenterol 1994;89:153-7.
86. Eggermont E, De Boeck K. Small intestinal abnormalities in cystic fibrosis patients. Eur J Pediatr 1991;150:824-8.
87. Jeffrey I, Durrans D, Wells M, Fox H. The pathology of meconium ileus equivalent. J Clin Pathol 1983;36:1292-7.
88. Wesley A, Forstner J, Qureshi R, Mantle M, Forstner G. Human intestinal mucin in cystic fibrosis. Pediatr Res 1983;17:65-9.
89. Zentler-Munro PL, Hodson ME, Batten JC. Meconium ileus equivalent in older patients with cystic fibrosis. Br Med J 1983;287:501-2.
90. Menzies IS. Transmural passage of inert molecules in health and disease. In: Skadhauge E, Heintz K, eds. Intestinal absorption and secretion. Lancaster: MTP Press, 1984:527-43.
91. Bjarnason I. Intestinal permeability barriers. In: Peeters TJ, eds. The cell biology of inflammation in the gastrointestinal trad. Hull: Corners Publication, 1990:127-42.
92. Fordtran JS, Rector FC, Ewton MF, Soter N, Kinney J. Permeability characteristics of the human small intestine. J Clin Invest 1965;44:1935-44.
93. Billich CO, Levitan R. Effects of sodium concentration and osmolarity on water and electrolyte absorption from the intact human colon. J Clin Invest 1969;48:1330-47.
94. Bjarnason I. Intestinal permeability. Gut 1994;35(suppl 1): S18-22.
95. Cobden I, Dickinson RJ, Rothwell J, Ascon ATR. Intestinal permeability assessed by excretion rates of two molecules: results in coeliac disease. Br Med J 1978;2:1060.
96. Penny DJ, Ingall CB, Boulton P, Walker-Smith JA, Basheer SM. Intestinal malabsorption in cystic fibrosis. Arch Dis Child 1986;61:1127-8.
97. Leclerq-Foucart J, Forget PP, van Cutsem JL. Lactuloserhamnose intestinal permeability in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 1987;6:66-70.
98. Freye HB, Kurtz S, Spock A, Capp M. Light and electron microscopic examinations of the small bowel of children with cystic fibrosis. J Pediatr 1964;64:575-9.
99. Gosden CM, Gosden JR. Fetal abnormalities in cystic fibrosis suggest a deficiency in proteolysis of cholecystokinin. Lancet 1984;2:541-6.
100. Mack DR, Flick JA, Durie PR, Rosenstein BJ, Ellis LE, Perman JA. Correlation of intestinal lactulose permeability with exocrine pancreatic dysfunction. J Pediatr 1992;120: 696-701.
101. Leclerq-Foucart J, Forget P, Sodoyez-Goffaux F, Zappitelli A. Intestinal permeability to 51-CrEDTA in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 1986;5: 384-7.
102. Murphy MS, Sheldon W, Brunetto A, et al. Active and passive sugar absorption in pancreatic insufficiency. J Pediatr Gastroenterol Nutr 1989;8:189-94.
103. Freel RW, Hatch M, Earnest DL, Goldner AM. Role of tight-junctional pathways in bile salt induced increases in colonic permeability. Am J Physiol 1983;245:G816-23.
104. Goodchild MC, Murphy GM, Howell AM, Nutter SA, Anderson CM. Aspects of bile acid metabolism in cystic fibrosis. Arch Dis Child 1975;50:769-78.
105. Sinaasappel M. Relationship between intestinal function and chloride secretion in patients with cystic fibrosis. Neth J Med 1992;41:110-4.
106. Miller MA, Parkman HP, Brown KL, et al. The lactulose breath test is not a physiologic standard for orocecal transit: lactulose delays gastric emptying and accelerates small bowel transit. Gastroenterology 1995;108(suppl):A650.
107. Dunaif G, Schneeman BO. The effect of dietary fibre on human pancreatic enzyme activity in vitro. Am J Clin Nutr 1981;34:1034-5.
108. Jones R, Franklin K, Spicer R, Berry J. Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes. Lancet 1995;346:499.
109. van Velzen D. Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes. Lancet 1995; 346:499-500.
110. Lillemoe KD, Johnson LF, Harmon JW. Alkaline esophagitis: a comparison of the ability of components of gastroduodenal contents to injure the rabbit esophagus. Gastroenterology 1983;85:621-8.
111. Ablin DS, Ziegler M. Ulcerative type of colitis associated with the use of high strength pancreatic enzyme supplements in cystic fibrosis. Pediatr Radiol 1995;25:113-5.
112. Smyth RL, Ashby D, O'Hea U, et al. Fibrosing colonopathy in cystic fibrosis: results of a case-control study. Lancet 1995;346:1247-51.